Search research articles
Contact Us
Filters
Showing results (171-180 of 176) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 176 results.
Science (New York, N.Y.)
|
August 11, 2012
Loss of the tumor suppressor BAP1 causes myeloid transformation
Anwesha Dey, Dhaya Seshasayee, Rajkumar Noubade, et al.
Nature
|
March 4, 2011
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E Wertz, Saritha Kusam, Cynthia Lam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 19, 2021
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation
Yixuan Zhou, Ingmar Niels Bastian, Mark D Long, et al.
Science Signaling
|
April 20, 2017
The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation
Kate Senger, Victoria C Pham, Eugene Varfolomeev, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Nature Communications
|
June 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model
Thijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 176) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 176 results.
Science (New York, N.Y.)
|
August 11, 2012
Loss of the tumor suppressor BAP1 causes myeloid transformation
Anwesha Dey, Dhaya Seshasayee, Rajkumar Noubade, et al.
Nature
|
March 4, 2011
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E Wertz, Saritha Kusam, Cynthia Lam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 19, 2021
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation
Yixuan Zhou, Ingmar Niels Bastian, Mark D Long, et al.
Science Signaling
|
April 20, 2017
The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation
Kate Senger, Victoria C Pham, Eugene Varfolomeev, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Nature Communications
|
June 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model
Thijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.
Page
of 18